Combating Phage Rage

Life Technologies' MAX Efficiency DH5a Competent Cells now guard against infection by bacteriophage T5 In the past, a researcher may have lost an Escherichia coli culture to a phage infection and just chalked it up to a failed transformation or inoculation. According to Heather Lustig, marketing manager for Life Technologies of Rockville, Md., bacteriophage contamination didn't really become a major concern until genome centers began sequencing large numbers of clones in parallel. Whereas good

Written byAmy Francis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Life Technologies' MAX Efficiency DH5a Competent Cells now guard against infection by bacteriophage T5
In the past, a researcher may have lost an Escherichia coli culture to a phage infection and just chalked it up to a failed transformation or inoculation. According to Heather Lustig, marketing manager for Life Technologies of Rockville, Md., bacteriophage contamination didn't really become a major concern until genome centers began sequencing large numbers of clones in parallel. Whereas good sterile technique averts contamination by many microbiological culprits, some bacteriophage are airborne and thus present a particular challenge. As Life Technologies' principal scientist, Fred Bloom, points out, "Bacteriophage can destroy your genomic stock and wipe out years and years of work." At the request of customers, Life Technologies recently released a bacteriophage T1-resistant version of its popular MAX Efficiency DH5a Competent Cells.

Product development began when scientists at Life Technologies isolated a bacteriophage T5-resistant derivative of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies